INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2020

Psyllium consumption significantly reduced triglycerides, LDL cholesterol, fasting blood sugar, and HbA1c in patients with diabetes.

A systematic review and meta-analysis of eight randomized controlled trials evaluated the effects of psyllium in 395 diabetic participants. Psyllium consumption led to significant reductions in triglycerides (WMD: -19.18 mg/dl, 95% CI [-31.76, -6.60]), low-density lipoprotein (WMD: -8.96 mg/dl, 95% CI [-13.39, -4.52]), fasting blood sugar (WMD: -31.71 ml/dl, 95% CI [-50.04, -13.38]), and hemoglobin A1c (WMD: -0.91%, 95% CI [-1.31, -0.51]). There were no significant changes in high-density lipoprotein, body mass index, cholesterol, or weight.

Study type
Systematic review and dose-response meta-analysis of RCTs
Who was studied
395 diabetic participants across 8 studies (9 arms)
What was measured
Weight, BMI, lipid profiles (TG, LDL, HDL, total cholesterol), and glucose metabolism (FBS, HbA1c)

THE PAPER

The effect of psyllium consumption on weight, body mass index, lipid profile, and glucose metabolism in diabetic patients: A systematic review and dose-response meta-analysis of randomized controlled trials.

Xiao Z, Chen H, Zhang Y, Deng H, Wang K, Bhagavathula AS, Almuhairi SJ, Ryan PM, Rahmani J, Dang M, Kontogiannis V, Vick A, Wei Y. Phytother Res, 2020.

PubMed 31919936 ↗DOI 10.1002/ptr.6609 ↗

Heart & arteriesDiabetes & blood sugarNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.